I don't think Shire will pull a Pfizer on Intellect, however, if Shire is acquired by another big pharma then there could be something like what has happened between Pfizer and Intellect. I still don't know if Intellect would even receive anything from a successful phase 1b/2 trial. So the only way for Intellect to see money is to dilute the stock like it has done since it began trading.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.